These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 9660843)

  • 41. Effect of itraconazole on the pharmacokinetics and pharmacodynamics of zolpidem.
    Luurila H; Kivistö KT; Neuvonen PJ
    Eur J Clin Pharmacol; 1998 Apr; 54(2):163-6. PubMed ID: 9626922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Pharmacokinetics and pharmacodynamics of zolpidem following repeated doses in hemodialyzed uraemic patients.
    Fillastre JP; Geffroy-Josse S; Etienne I; Dhib M; Rosenzweig P; Danjou P; Dubruc C; Bianchetti G
    Fundam Clin Pharmacol; 1993; 7(1):1-9. PubMed ID: 8458597
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Clinical pharmacokinetics and pharmacodynamics of zolpidem. Therapeutic implications.
    Salvà P; Costa J
    Clin Pharmacokinet; 1995 Sep; 29(3):142-53. PubMed ID: 8521677
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men.
    Olubodun JO; Ochs HR; von Moltke LL; Roubenoff R; Hesse LM; Harmatz JS; Shader RI; Greenblatt DJ
    Br J Clin Pharmacol; 2003 Sep; 56(3):297-304. PubMed ID: 12919178
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Investigation of pharmacokinetic and pharmacodynamic interactions after coadministration of nefazodone and haloperidol.
    Barbhaiya RH; Shukla UA; Greene DS; Breul HP; Midha KK
    J Clin Psychopharmacol; 1996 Feb; 16(1):26-34. PubMed ID: 8834415
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effect of alosetron on the pharmacokinetics of fluoxetine.
    D'Souza DL; Dimmitt DC; Robbins DK; Nezamis J; Simms L; Koch KM
    J Clin Pharmacol; 2001 Apr; 41(4):455-8. PubMed ID: 11304903
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Excretion of fluoxetine and its metabolite, norfluoxetine, in human breast milk.
    Taddio A; Ito S; Koren G
    J Clin Pharmacol; 1996 Jan; 36(1):42-7. PubMed ID: 8932542
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Pharmacokinetics of zolpidem from sublingual zolpidem tartrate tablets in healthy elderly versus non-elderly subjects.
    Greenblatt DJ; Harmatz JS; Singh NN; Steinberg F; Roth T; Harris SC; Kapil RP
    Drugs Aging; 2014 Oct; 31(10):731-6. PubMed ID: 25246162
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Pharmacokinetic pharmacodynamic evaluation of the combined administration of alprazolam and fluoxetine.
    Lasher TA; Fleishaker JC; Steenwyk RC; Antal EJ
    Psychopharmacology (Berl); 1991; 104(3):323-7. PubMed ID: 1924640
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Pharmacokinetics and brain distribution of zolpidem in the rat after acute and chronic administration.
    Trenque T; Bustany P; Lamiable D; Legros S; Choisy H
    J Pharm Pharmacol; 1994 Jul; 46(7):611-3. PubMed ID: 7996394
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Preliminary assessment of zolpidem pharmacokinetics in pediatric burn patients.
    Stockmann C; Sherwin CM; Buterbaugh W; Spigarelli MG; Gottschlich MM; Healy D; Kagan RJ
    Ther Drug Monit; 2014 Jun; 36(3):295-301. PubMed ID: 24365985
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of CYP3A4 metabolism on sex differences in the pharmacokinetics and pharmacodynamics of zolpidem.
    Yoon S; Jeong S; Jung E; Kim KS; Jeon I; Lee Y; Cho JY; Oh WY; Chung JY
    Sci Rep; 2021 Sep; 11(1):19150. PubMed ID: 34580385
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Zolpidem 10 mg given at daytime is not antagonized by 300 mg caffeine in man.
    Mattila MJ; Nurminen ML; Vainio P; Vanakoski J
    Eur J Clin Pharmacol; 1998 Jul; 54(5):421-5. PubMed ID: 9754987
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Pharmacokinetics of fluoxetine in pregnant baboons (Papio spp.).
    Shoulson RL; Stark RL; Garland M
    J Am Assoc Lab Anim Sci; 2014 Nov; 53(6):708-16. PubMed ID: 25650979
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of Mirogabalin When Coadministered With Lorazepam, Zolpidem, Tramadol, or Ethanol: Results From Drug-Drug Interaction Studies in Healthy Subjects.
    Jansen M; Mendell J; Currie A; Dow J; He L; Merante D; Dishy V; Ishizuka H; Zahir H
    Clin Pharmacol Drug Dev; 2018 Aug; 7(6):597-612. PubMed ID: 29870596
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Possible interactions between zolpidem, a new sleep inducer and chlorpromazine, a phenothiazine neuroleptic.
    Desager JP; Hulhoven R; Harvengt C; Hermann P; Guillet P; Thiercelin JF
    Psychopharmacology (Berl); 1988; 96(1):63-6. PubMed ID: 3147477
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Delirium associated with zolpidem.
    Brodeur MR; Stirling AL
    Ann Pharmacother; 2001 Dec; 35(12):1562-4. PubMed ID: 11793620
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of zolpidem on operant behavior and its relation to pharmacokinetics after intravenous and subcutaneous administration: concentration-effect relations.
    Lau CE; Sun L; Wang Q; Falk JL
    Behav Pharmacol; 2002 Mar; 13(2):93-103. PubMed ID: 11981222
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Lack of pharmacokinetic interaction when switching from fluoxetine to milnacipran.
    Puozzo C; Hermann P; Chassard D
    Int Clin Psychopharmacol; 2006 May; 21(3):153-8. PubMed ID: 16528137
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Fluoxetine in depressed patients with renal failure and in depressed patients with normal kidney function.
    Levy NB; Blumenfield M; Beasley CM; Dubey AK; Solomon RJ; Todd R; Goodman A; Bergstrom RR
    Gen Hosp Psychiatry; 1996 Jan; 18(1):8-13. PubMed ID: 8666216
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.